andrew huberman bpc 157 recommendations Safety BPC 157 | Ask Huberman

Who should not get B12 injections

Several things could be happening: The vial might be too cold

We currently ship within the United States only

505 After a three-year follow-up investigation, 54.1% and 56.3% of patients randomized to the ustekinumab q12w and q8w groups, respectively, achieved symptomatic relief at week 152 while on maintenance therapy

Vitamin B12, also known as cobalamin, is a water-soluble vitamin thats involved in various essential bodily processes

Experts cautioned that more research is needed before broad conclusions can be drawn, but the results do provide some evidence that robust immunity is generated after one dose and that the second dose could be delayed beyond the three weeks prescribed by Pfizer in order to ease distribution and supply constraints